Company Filing History:
Years Active: 2021
Title: Katherine Fells: Innovator in Antibody Drug Conjugates
Introduction
Katherine Fells is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. Her innovative work has the potential to impact the treatment of various diseases, including multiple myeloma.
Latest Patents
Katherine Fells holds 1 patent for her invention of a CD38 antibody drug conjugate. This patent discloses an antibody drug conjugate (ADC) that features an IgG antibody binding to a CD38 target, conjugated at a Cys site in the hinge region of the IgG antibody. The patent also outlines a method for treating multiple myeloma by providing an effective amount of the CD38 ADC.
Career Highlights
Katherine is currently employed at Sorrento Therapeutics, Inc., where she continues to advance her research and development efforts. Her work at Sorrento Therapeutics has positioned her as a key player in the biotechnology sector, focusing on innovative therapeutic solutions.
Collaborations
Katherine collaborates with talented professionals in her field, including Tong Zhu and Alisher B Khasanov. These collaborations enhance her research and contribute to the advancement of antibody drug conjugate technology.
Conclusion
Katherine Fells is a dedicated inventor whose work in antibody drug conjugates is paving the way for new treatment options in oncology. Her contributions to the field exemplify the importance of innovation in healthcare.